Chad Messer
Stock Analyst at Lake Street
(0.53)
# 4,044
Out of 5,182 analysts
29
Total ratings
23.33%
Success rate
-20.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintains: Buy | $22 → $32 | $21.84 | +46.52% | 2 | Dec 16, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.36 | +1,150.00% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $2.57 | +522.57% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $55.13 | +92.27% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $4.29 | +1,648.25% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $0.96 | +628.94% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $4.01 | +299.00% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $1.62 | +1,443.21% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $2.61 | +4,267.82% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $112.63 | -55.61% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $66.73 | -28.07% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $43.88 | -31.63% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $7.05 | +311.35% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.32 | +3,025.00% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $74.79 | +14.99% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $15.51 | +183.69% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $23.23 | +614.59% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.38 | +1,204.35% | 1 | May 5, 2020 |
Immunome
Dec 16, 2025
Maintains: Buy
Price Target: $22 → $32
Current: $21.84
Upside: +46.52%
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.36
Upside: +1,150.00%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $2.57
Upside: +522.57%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $55.13
Upside: +92.27%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $4.29
Upside: +1,648.25%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $0.96
Upside: +628.94%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $4.01
Upside: +299.00%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $1.62
Upside: +1,443.21%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $2.61
Upside: +4,267.82%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $112.63
Upside: -55.61%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $66.73
Upside: -28.07%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $43.88
Upside: -31.63%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $7.05
Upside: +311.35%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $0.32
Upside: +3,025.00%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $74.79
Upside: +14.99%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $15.51
Upside: +183.69%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $23.23
Upside: +614.59%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.38
Upside: +1,204.35%